This comparison report shows that the activated T cells are significantly increased, and the Regulatory T cells significantly declined after the cancer treatment, which means this patient’s immune system can kill more cancer cells in the body. This is a study on a patient with colorectal cancer.Continue reading
Mr. Chu is a 58 years old Chinese male with diagnosis of colon cancer.
In November 2007, at the outer line of sigmoid colon cancer resection, he was given after four cycles of Eloxatin and Xeloda chemotherapy. In February 2008, Mr. Chu prompted to relapse by colonoscopy, with second surgery at a cancer hospital in Shanghai, after surgery revealed no metastasis, the original course of chemotherapy continued for six weeks.Continue reading
Mr. Bauer is a 60 years old man from the USA. He was diagnosed with colon cancer with metastasis to liver and lung in 2011.
He had surgery and rounds of chemotherapy, however the treatment outcomes were not so good. His weakened condition did not allow him to continue the chemotherapy and the trauma caused by surgery. He searched online and realized that the immunotherapy may be a new choice for him.Continue reading